FDA Webview
X
about-us-banner

Articles

Home /Articles / FDA Federal Register Notices

Travatan Not Withdrawn for S&E

11/16/2011

Federal Register Notice: FDA has determined that Travatan (travoprost ophthalmic solution), 0.004%, was not withdrawn from sale fo...

Info on Extra-label Drug Use Sent to OMB

11/16/2011

Federal Register Notice: FDA’s proposed collection, “Extra-label Drug Use in Animals — 21 CFR 530” has bee...

OMB OKs Info on Exemption for Preemption

11/16/2011

Federal Register Notice: FDA’s collection of information, “State Petitions for Exemption for Preemption,” has be...

Date Corrected in Guidance Notice

11/16/2011

Federal Register Notice: FDA is correcting a date in a 10/20 Federal Register notice announcing the availability of a draft guidan...

Comments on Allergic Disease Treatment Extended

11/16/2011

Federal Register Notice: FDA is extending to 4/25/12 the comment period for the notice on its report of scientific and medical lit...

Panel to Discuss Cranial Electrotherapy Device Reclassification

11/16/2011

Comments Sought on Device Mfr. Electronic Submissions

11/03/2011

Public Workshop on Developing Sedation Products

11/03/2011

Federal Register Notice: CDER will hold a scientific workshop 5/3/12 to solicit information on a variety of issues related to the ...

FDA to Amend Orphan Drug Regulations

10/19/2011

Federal Register Proposed rule: FDA is proposing to amend the 1992 Orphan Drug Regulations issued to implement the Orphan Drug Act...

Info on Substances Prohibited in Animal Feed Sent to OMB

10/19/2011